Figure Legends: 
Figure 1. Adjusted time to event plots for chronic complications, device reinterventions, heart failure hospitalizations, and all-cause mortality out to 3 years of follow-up in patients treated with leadless VVI versus transvenous VVI pacing.  A) Hazard ratio (HR) and cumulative incidence function for 3-year chronic complications based on the Fine-Gray competing risk model.  B) HR and cumulative incidence function for 3-year device reinterventions based on the Fine-Gray competing risk model. B) HR and cumulative incidence function for 3-year heart failure hospitalizations based on the Fine-Gray competing risk model. D) HR and patient mortality rates based on the Cox proportional hazards model. CI = 95% confidence interval.